HB
GSK icon

Horizon Bancorp’s GSK GSK Stock Holding History

Horizon Bancorp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Buy
5,540
+1,600
+41% +$86.7K 0.15% 48
2025
Q4 		$193K Sell
3,940
-2,095
-35% -$97.7K 0.09% 76
2025
Q3 		$261K Buy
6,035
+2,244
+59% +$87.7K 0.12% 61
2025
Q2 		$146K Sell
3,791
-104
-3% -$3.97K 0.07% 94
2025
Q1 		$151K Sell
3,895
-340
-8% -$12.4K 0.09% 73
2024
Q4 		$143K Sell
4,235
-134
-3% -$4.82K 0.07% 80
2024
Q3 		$179K Sell
4,369
-214
-5% -$8.76K 0.08% 73
2024
Q2 		$176K Buy
4,583
+551
+14% +$23.2K 0.08% 67
2024
Q1 		$173K Buy
4,032
+71
+2% +$2.93K 0.08% 72
2023
Q4 		$147K Buy
3,961
+323
+9% +$11.6K 0.07% 76
2023
Q3 		$132K Buy
3,638
+3,317
+1,033% +$118K 0.08% 67
2023
Q2 		$11K Buy
+321
New +$11.5K 0.01% 186
2020
Q2 		– Sell
-2,400
Closed -$114K – 253
2020
Q1 		$114K Buy
2,400
+1,960
+445% +$105K 0.18% 138
2019
Q4 		$26K Buy
+440
New +$24.5K 0.02% 216

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Horizon Bancorp's GSK Position: Q1 2026 in Review

Horizon Bancorp increased its GSK (GSK) stake by 41% in Q1 2026, buying an estimated $86.7K and bringing the position to 5,540 shares worth $306K. The position accounts for 0.15% of the portfolio, ranked #48.

Horizon Bancorp first reported a position in GSK in Q4 2019 and has held it in 14 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Horizon Bancorp held 5,540 shares of GSK worth $306K as of Q1 2026.
  • Horizon Bancorp bought 1,600 GSK shares in Q1 2026, an estimated $86.7K.
  • GSK made up 0.15% of Horizon Bancorp's portfolio in Q1 2026, its #48 holding.
  • Horizon Bancorp first reported a position in GSK in Q4 2019 and has held it in 14 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.